FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095821 [Registered on: 09/10/2025] Trial Registered Prospectively
Last Modified On: 29/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   A study on Irritable Bowel Syndrome treatment using Boger Boenninghausens characteristics and repertory. 
Scientific Title of Study   The Clinical Utility Of Boger Boenninghausens Characteristics and Repertory in the Management of Irritable Bowel Syndrome 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ancin A N 
Designation  Junior Resident Department of Homoeopathic Repertory and Case Taking 
Affiliation  White Memorial Homoeopathy Medical College, Attoor 
Address  Department of Homoeopathic Repertory and case taking White memorial Homoeo medical college and hospital Attoor Veeyanoor Kanniyakumari district

Kanniyakumari
TAMIL NADU
629177
India 
Phone  8300913983  
Fax    
Email  ancinan1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR R K DOMININ RAJ  
Designation  PROFESSOR Department of Homoeopathic Repertory and Case Taking 
Affiliation  White Memorial Homoeopathy Medical College, Attoor 
Address  Department of Homoeopathic Repertory and case taking White memorial Homoeo medical college and hospital Attoor Veeyanoor Kanniyakumari district

Kanniyakumari
TAMIL NADU
629177
India 
Phone  9447654467  
Fax    
Email  drdomininrajrk@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR R K DOMININ RAJ  
Designation  PROFESSOR Department of Homoeopathic Repertory and Case Taking 
Affiliation  White Memorial Homoeopathy Medical College, Attoor 
Address  Department of Homoeopathic Repertory and case taking White memorial Homoeo medical college and hospital Attoor Veeyanoor Kanniyakumari district

Kanniyakumari
TAMIL NADU
629177
India 
Phone  9447654467  
Fax    
Email  drdomininrajrk@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF HOMOEOPATHIC REPERTORY AND CASE TAKING WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL ATTOOR KANNIYAKUMARI TAMILNADU 
 
Primary Sponsor  
Name  Department of Homoeopathic Repertory and Case Taking,White Memorial Homoeopathy Medical College 
Address  White Memorial Homoeopathy Medical College Attoor Kanniyakumari Tamilnadu 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ancin A N  WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL   DEPARTMENT OF HOMOEOPATHIC REPERTORY AND CASE TAKING OPD UNITS ,HEALTH CAMPS AND PERIPHERAL CENTERS , KANNIYAKUMARI TAMILNADU
Kanniyakumari
TAMIL NADU 
8300913983

ancinan1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL ETHICS COMMITTEE WMHMCH-EC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K58||Irritable bowel syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised Homoeopathic medicine  Homoeopathic Medicine selected based on symptom similarity will be administered to the patients in proper dose potency and repetition of medicine according to the homoeopathic principle. 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Age group from 35 to 50 years.
Sex: Male & Female
All cases that fit into ROME 1V diagnostic criteria.

 
 
ExclusionCriteria 
Details  Cases that do not satisfy the ROME IV criteria.
Patient who are already under treatment for Gastrointestinal disorders.
Pregnant and lactation women.
Patients suffering from other systemic illness who are under medication.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessment of Improvement will be done by IBS-SSS Before and after treatment.Outcome will be classified as follows:
• MARKED IMPROVEMENT: More than 75% score
• MODERATE IMPROVEMENT: 40-75%
• MILD IMPROVEMENT: 5-40%
• NO IMPROVEMENT:Less than 5%
 
6 months 
 
Secondary Outcome  
Outcome  TimePoints 
TO understanding The utility of Boger Boenninghusens Characteristics and Repertory.  6 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [ancinan1998@gmail.com].

  6. For how long will this data be available start date provided 12-09-2025 and end date provided 05-09-2030?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary   To assess the relief symptoms in irritable bowel syndrome and their changes in level score after homoeopathic treatment using Boger Boenninghausen’s characteristics and repertory with individualised homoeopathy medicine with two weeks once follow up . 
Close